Thomas Gad - 01 Feb 2022 Form 4 Insider Report for Y-mAbs Therapeutics, Inc. (YMAB)

Role
Chairman, President and Head of Business Development & Strategy, Director
Signature
/s/ THOMAS GAD
Issuer symbol
YMAB
Transactions as of
01 Feb 2022
Net transactions value
-$65,161
Form type
4
Filing time
03 Feb 2022, 16:00:53 UTC
Previous filing
26 Jan 2022
Next filing
07 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction YMAB Common Stock Options Exercise $16,000 +8,000 +16% $2.00 58,000 01 Feb 2022 Direct F1
transaction YMAB Common Stock Sale $81,161 -8,000 -14% $10.15 50,000 01 Feb 2022 Direct F2, F3
holding YMAB Common Stock 982,366 01 Feb 2022 By GAD Enterprises LLC F4
holding YMAB Common Stock 60,000 01 Feb 2022 By Children F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction YMAB Employee Stock Option (right to buy) Options Exercise $0 -8,000 -5% $0.000000 153,000 01 Feb 2022 Common Stock 8,000 $2.00 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired through the exercise of Employee Stock Options.
F2 Represents shares sold pursuant to a Rule 10b5-1 trading plan adopted on 12/14/2021.
F3 This transaction was executed in multiple trades at prices ranging from $9.91 to $10.33. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 Reporting Person is sole member of GAD Enterprises, LLC and the sole member and manager of GAD Management, LLC, the manager of GAD Enterprises, LLC, and as such Reporting Person has sole voting and dispositive power with respect to such shares.
F5 Represents shares owned by Reporting Person's children who are deemed to share Reporting Person's household.
F6 The stock option vested and became exercisable as to 25% of the shares subject to the option on June 10, 2016, and thereafter vested as to 1/48th of the shares in equal monthly installments, until such time as the option was 100% vested on June 10, 2019.

Remarks:

Chairman, President and Head of Business Development & Strategy